PREVALENCE OF FRACTURES IN POSTMENOPAUSAL WOMEN WITH THYROID-DISEASE

被引:108
作者
SOLOMON, BL [1 ]
WARTOFSKY, L [1 ]
BURMAN, KD [1 ]
机构
[1] WALTER REED ARMY MED CTR,DEPT CLIN INVEST,WASHINGTON,DC 20307
关键词
D O I
10.1089/thy.1993.3.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We interviewed 300 white postmenopausal women (160 with thyroid disease, 140 without thyroid disease) to investigate whether having thyroid disease or taking thyroid hormone increased the prevalence of having a hip, vertebral, or forearm fracture. Thirty-seven (23%) women with thyroid disease and 45 (32%) women without thyroid disease had had a fracture, and there were no significant differences between these groups in the number or type of fractures. Dose of thyroid hormone and duration of therapy or disease did not affect fracture occurrence in women with thyroid disease. Women with a history of hyperthyroidism (9 of 32) or thyroid cancer (2 of 11) appeared to have their first fracture earlier (p < 0.01) than women without thyroid disease. In summary, women taking thyroid hormone for a variety of thyroid disorders do not appear to have an enhanced prevalence of a hip, vertebral, or forearm fractures, but women with a history of hyperthyroidism may have a propensity for their fractures to occur earlier in life.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 23 条
[1]   BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH L-THYROXINE [J].
ADLIN, EV ;
MAURER, AH ;
MARKS, AD ;
CHANNICK, BJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 90 (03) :360-366
[2]  
BAUER DC, 1992, AM SOC BONE MINER S, V1, pS121
[3]  
COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48
[4]   LIFETIME RISKS OF HIP, COLLES, OR VERTEBRAL FRACTURE AND CORONARY HEART-DISEASE AMONG WHITE POSTMENOPAUSAL WOMEN [J].
CUMMINGS, SR ;
BLACK, DM ;
RUBIN, SM .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) :2445-2448
[5]   A THERAPEUTIC DILEMMA - SUPPRESSIVE DOSES OF THYROXINE SIGNIFICANTLY REDUCE BONE-MINERAL MEASUREMENTS IN BOTH PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH THYROID-CARCINOMA [J].
DIAMOND, T ;
NERY, L ;
HALES, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1184-1188
[6]  
DUNCAN WE, 1992, AM SOC BONE MINERA S, V1, pS328
[7]  
ETTINGER B, 1982, WESTERN J MED, V136, P473
[8]   EXOGENOUS HYPERTHYROIDISM WITH OSTEOPOROSIS [J].
FALLON, MD ;
PERRY, HM ;
BERGFELD, M ;
DROKE, D ;
TEITELBAUM, SL ;
AVIOLI, LV .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) :442-444
[9]  
FRASER SA, 1971, LANCET, V1, P981
[10]   EFFECT OF THYROXINE THERAPY ON BONE METABOLISM IN SUBSTITUTED HYPOTHYROID PATIENTS WITH NORMAL OR SUPPRESSED LEVELS OF TSH [J].
GAM, AN ;
JENSEN, GF ;
HASSELSTROM, K ;
OLSEN, M ;
NIELSEN, KS .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (06) :451-455